Clinical Trial Update: Tocotrienol as a Nutritional Supplement in Patients With Advanced Lung Cancer [Phase 3]

View source ↗

Summary

Phase 3 clinical trial of tocotrienol as a nutritional supplement in patients with advanced lung cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Drugs mentioned

• Tocotrienol (tocotrienol (vitamin E) supplement)

Snippet

Sponsor: Vejle Hospital | Conditions: Lung Cancer | Phase 3 | Status: TERMINATED